<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00778323</url>
  </required_header>
  <id_info>
    <org_study_id>XJ20070901</org_study_id>
    <nct_id>NCT00778323</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Remote Preconditioning in Patients Undergoing Cervical Decompression Surgery</brief_title>
  <official_title>Effects of Remote Ischemic Preconditioning on Biochemical Markers and Neurological Outcomes in Patients Undergoing Elective Cervical Decompression Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether a large clinical trial testing the effect of
      RIPC on neurologic outcome in patients undergoing elective cervical decompression surge is
      warranted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spinal cord ischemia-reperfusion injury commonly contribute to perioperative morbidity and
      mortality after elective cervical decompression surgery.Remote ischemic
      preconditioning(RIPC)is a phenomenon whereby brief periods of ischemia followed by
      reperfusion in one organ provide system protection from prolonged ischemia.The hypothesis of
      this protocol is that limb ischemic preconditioning could reduces spinal cord
      ischemia-reperfusion injury induced by elective cervical decompression surgery.Serum s-100B
      and NSE concentration will be measured before and after induction ,and at 6 hours,1,3,5 and
      7days after surgery.JOA scores in all the cases will be evaluated before operation and at
      7days ,1,3,6 month after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum concentrations of s-100B,NSE</measure>
    <time_frame>1 week or more</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>a Japanese Orthopaedic Association (JOA) scale</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Cervical Compression Myelopathy</condition>
  <condition>Ischemia</condition>
  <condition>Reperfusion Injury</condition>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>A,2, II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>limb remote ischemic preconditioning (LRIPC)</intervention_name>
    <description>LRIPC consists of three 5-min cycles of right upper limb ischemia induced by an automated cuff-inflator placed on the upper arm and inflated to 200 mmHg,with an intervening 5 min reperfusion during which the cuff is deflated.</description>
    <arm_group_label>A,2, II</arm_group_label>
    <other_name>an automated cuff-inflator made in China</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with clinical and radiological signs of cervical compression myelopathy(ccm)

          -  Age 30-75

          -  Stage 1-2

        Exclusion Criteria:

          -  Age&gt;75

          -  History of heart,hepatic,renal or pulmonary disease.

          -  History of peripheral vascular disease affecting the upper limbs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lize Xiong, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Xiling Hospital,Fourth Military Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2008</study_first_submitted>
  <study_first_submitted_qc>October 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2008</study_first_posted>
  <last_update_submitted>February 24, 2011</last_update_submitted>
  <last_update_submitted_qc>February 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2011</last_update_posted>
  <responsible_party>
    <name_title>Lize Xiong</name_title>
    <organization>Fourth Military Medical University</organization>
  </responsible_party>
  <keyword>remote ischemic preconditioning</keyword>
  <keyword>cervical compression myelopathy</keyword>
  <keyword>spinal cord</keyword>
  <keyword>neuron-specific enolase</keyword>
  <keyword>s-100B</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

